Skip to content

Neurological Consequences of Perinatal Listeriosis Infection

Multicentric Observational National Analysis of Listeriosis and Listeria : Evaluation of the Neurological Consequences of Perinatal Listeriosis Infection

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02580812
Acronym
MONALISABABY
Enrollment
53
Registered
2015-10-20
Start date
2015-10-26
Completion date
2018-10-29
Last updated
2025-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perinatal Listeriosis

Keywords

Perinatal listeriosis, Neurological impairment, Sepsis, Prematurity, Neurotropism, Listeria monocytogenes, Intellectual Quotient

Brief summary

The purpose of the study is to determine whether perinatal listeriosis is associated with long-term neurological consequences, and to evaluate the respective contribution of perinatal sepsis, of prematurity and of the known neurological tropism of the involved pathogen, Listeria monocytogenes.

Detailed description

Perinatal listeriosis is defined by the occurrence of maternal listeriosis at birth and/or of early-onset listeriosis in the neonate (defined by the positive culture of any sample of maternal or neonatal origin). Neurological involvement is defined by the presence of inflammation of the cerebrospinal fluid of positive culture or the cerebro-spinal fluid. Evaluation is performed at the age of 5 years, and includes WPPSI evaluation of the Intelligence Quotient (IQ), NEPSY evaluation of the executive functions and clinical evaluation checking for any motor, sensorial or other focal deficiency among 90 cases and 270 controls matched for gestational age.

Interventions

OTHERClinical and neuropsychological evaluation procedure

WPPSI, NEPSY, Brief, SDQ, Vineland and SCQ evaluation Clinical examination

Sponsors

Institut Pasteur
CollaboratorINDUSTRY
Institut National de la Santé Et de la Recherche Médicale, France
CollaboratorOTHER_GOV
URC-CIC Paris Descartes Necker Cochin
CollaboratorOTHER
Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
5 Years to 6 Years
Healthy volunteers
No

Inclusion criteria

* Children from the MONALISA cohort (culture proven-maternal listeriosis) * Or Children from the EPIPAGE cohort (control group) * Written consent from the parent(s) or legal representative

Exclusion criteria

* Children whose parents or legal representative would deny their consent

Design outcomes

Primary

MeasureTime frameDescription
Reduction of > 20 points of the Intellectual QuotientDay 1Evaluated by standard tests (WPPSI-IV)

Secondary

MeasureTime frameDescription
Score obtained at SDQ evaluation test (Strenghts and Difficulties Questionnaire)Day 1to evaluate alteration of cognitive functions
Score obtained at SCQ evaluation test (Social Communication Questionnaire)Day 1to evaluate alteration of cognitive functions
Score obtained at BRIEF-P evaluation test (Behavior Rating Inventoring Executive Function)Day 1to evaluate alteration of executive functions
Score obtained at M-ABC evaluation test (Movement-ABC)Day 1to evaluate alteration of executive functions
Score obtained at Vineland ScaleDay 1
Scores obtained at NEPSY-2 evaluation testsDay 1
Score obtained at HOME evaluation test (Home Observation and Measurement of Environment)Day 1

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 10, 2026